Health

Do orphan drugs deliver more survival gains per patient than non-orphan drugs? – Healthcare Economist

• Health

Do orphan drugs deliver more survival gains per patient than non-orphan drugs? – Healthcare Economist

Ak July 8, 2025

Traditional knowledge believes that orphan drugs treat rare (according to definition) and...

Read More Read more about Do orphan drugs deliver more survival gains per patient than non-orphan drugs? – Healthcare Economist

Friday Links

• Health

Friday Links

Ak July 5, 2025

Trends in non-care related to cost. OPTUM RX reduces the regeneration requirements. Changes in insulin out-of-pocket cost...

Read More Read more about Friday Links

Cost-effectiveness analysis model for sotagliflozin compared with insulin monotherapy for patients with type 1 diabetes and chronic kidney disease

• Health

Cost-effectiveness analysis model for sotagliflozin compared with insulin monotherapy for patients with type 1 diabetes and chronic kidney disease

Ak July 2, 2025

This is the title of my latest paper JMCP With co-author Jehong Kim, Shakshan Wang, Moise Marin,...

Read More Read more about Cost-effectiveness analysis model for sotagliflozin compared with insulin monotherapy for patients with type 1 diabetes and chronic kidney disease

Weekend Reading

• Health

Weekend Reading

Ak June 29, 2025

Naming schizophrenia: Why, how, and what next? Kovid -19 winner and losers. Labor market (not supply chain)...

Read More Read more about Weekend Reading

Impact of financial incentives on the value of the marginal drug – Healthcare Economist

• Health

Impact of financial incentives on the value of the marginal drug – Healthcare Economist

Ak June 26, 2025

From an interesting review letter in Economic approach journal By Craig Garthweight:...

Read More Read more about Impact of financial incentives on the value of the marginal drug – Healthcare Economist

Weekend Reading

• Health

Weekend Reading

Ak June 23, 2025

Impact of ‘a big beautiful bill’ on rural hospital finance Brain Implant gives the patient with ALS...

Read More Read more about Weekend Reading

What share of code is being written by AI? – Healthcare Economist

• Health

What share of code is being written by AI? – Healthcare Economist

Ak June 20, 2025

By a paper Danoti et al. (2025) examines 80 million github committees...

Read More Read more about What share of code is being written by AI? – Healthcare Economist

Do pay-for-performance programs actually improve quality of care? – Healthcare Economist

• Health

Do pay-for-performance programs actually improve quality of care? – Healthcare Economist

Ak June 17, 2025

It is one of the basic questions in health policy in recent years. Quality can be measured...

Read More Read more about Do pay-for-performance programs actually improve quality of care? – Healthcare Economist

Which states have the most private-equity owned hospitals? – Healthcare Economist

• Health

Which states have the most private-equity owned hospitals? – Healthcare Economist

Ak June 14, 2025

Private equity provides data reply from the stakeholder project (PESP). The data...

Read More Read more about Which states have the most private-equity owned hospitals? – Healthcare Economist

Consequences of Tariffs on Pharmaceutical Products – Healthcare Economist

• Health

Consequences of Tariffs on Pharmaceutical Products – Healthcare Economist

Ak June 11, 2025

This is the subject of one JMCP approach By Sean Sulivan, Jens Gruger, Adon Sullivan and Scott...

Read More Read more about Consequences of Tariffs on Pharmaceutical Products – Healthcare Economist